Abstract:PurposeHypofractionated radiotherapy of prostate cancer is gaining clinical acceptance given its potential increase in therapeutic ratio and evidence for noninferiority and lack of added late toxicities compared to conventional fractionation. However, concerns have been raised that smaller number of fractions might lead to larger dosimetric influence by interfractional motion. We aim to compare the effect of these variations on hypofractionated pencil beam scanning (PBS) proton therapy and volumetric modulated arc therapy (VMAT) for localized prostate cancer.MethodsWeekly CT images were acquired for 6 patients participating in a randomized clinical trial. PBS plans featuring bilateral (BL) and a combination of lateral and anterior-oblique beams (AOL), and VMAT plans were created. All patients were treated to a conventional 79.2Gy total dose in 44 fractions. For this study, hypofractionated dose to the prostate gland was 51.6Gy in 12 fractions or 36.25Gy in 5 fractions, and 32.8, and 23.1Gy to proximal seminal vesicles, respectively. Patients were simulated with endorectal balloons to aid gland immobilization. Three fiducial markers were implanted for setup guidance. All plans were recomputed on the weekly CT images after aligning with the simulation CT. The entire set of 9 CT images was used for dose recalculation for 12-fraction and only 5 used for the 5-fraction case. Adaptive range adjustments were applied to anterior-oblique beams assuming clinical availability of invivo range verification. Fractional doses were summed using deformable dose accumulation to approximate the delivered dose. Biologically equivalent dose to 2Gy(EQD2) was calculated assuming / of 1.5Gy for prostate and 3Gy for bladder and rectum.ResultsThe median delivered prostate D-98 was 0.13/0.14/0.13Gy(EQD2) smaller than planned for PBS-BL, 0.13/0.27/0.17Gy(EQD2) for PBS-AOL and 0.59/0.66/0.59Gy(EQD2) for VMAT, for 44/12/5 fractions, respectively. The largest D-98 reduction was 1.5 and 3.5Gy(EQD2) for CTV1 and CTV2, respectively. Target dose degradation was comparable for all fractionation schemes within each modality. The maximum increase in rectum D-2 was 0.98Gy(EQD2) for a 5-fraction PBS case.ConclusionsThe robustness of PBS and VMAT were comparable for all patients for the studied fractionations. The delivered target dose generally remained within clinical tolerance and the deviations were relatively minor for both fractionation schemes. The delivered OAR dose stayed in compliance with the RTOG hypofractionation constraints for all cases.

The motion amplitude of the adrenal occupying lesions and its influencing factors

Respiratory Motion of Adrenal Gland Metastases: Analyses Using Four-Dimensional Computed Tomography Images

Studies on the Mobility Rules of Lung Tumors and the Influencing Factors

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Differential diagnosis of adrenal metastasis and lipid-poor adrenal adenoma with CT

Total dose, fraction dose and respiratory motion management impact adrenal SBRT outcome

Motion of gastroesophageal junction adenocarcinoma during preoperative radiotherapy

Geometric and dosimetric consequences of intra-fractional movement in single isocenter non-coplanar stereotactic radiosurgery

Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe

The Impact of Respiratory Motion and Active Breathing Control on the Displacement of Target Area in Patients with Gastric Cancer Treated with Post-Operative Radiotherapy

The influence of respiratory movement on preoperative CT-guided localization of lung nodules

Impact of different anatomical landmarks on registration in imaging-guided radiation for lung cancer

Double CT Imaging Can Measure the Respiratory Movement of Small Pulmonary Tumors During Stereotactic Ablative Radiotherapy.

Factors influencing target volume motion in tangential whole breast irradiation for breast cancer

Anatomic Change over the Course of Treatment for Non–small Cell Lung Cancer Patients and Its Impact on Intensity-Modulated Radiation Therapy and Passive-Scattering Proton Therapy Deliveries

4DCT and CBCT Based PTV Margin in Stereotactic Body Radiotherapy(SBRT) of Non-Small Cell Lung Tumor Adhered to Chest Wall or Diaphragm

Dosimetric Effect of Target Position Accuracy on Single-Isocenter Multiple Liver Metastases SBRT

Study of Breath Control and Dosimetric Distribution in Intensity Modulated Radiotherapy fo non-small Cell Lung Cancer

Factors influencing target confirmation in three dimensional conformal radiotherapy for lung cancer

Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity

Intra‐ and inter‐fractional variations of tumors with fiducial markers measured using respiratory‐correlated computed tomography images for respiratory gated lung stereotactic body radiation therapy